AC

Albany Capital

Oceania, New South Wales, Australia, Sydney

Description

Albany Capital is an investment firm.

Investor Profile

Albany Capital has made 5 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (40%)
  • Series B (40%)
  • Series D (20%)

Country Focus

  • Germany (60%)
  • United States (40%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Agriculture
  • Farming
  • Productivity Tools
  • Retail
  • Software
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Albany Capital frequently co-invest with?

Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
TVM Capital Life Science
Europe, Bayern, Germany, Munich
Co-Investments: 3
Maize Partners
North America, Texas, United States, Dallas
Co-Investments: 1
Signet Healthcare Partners
North America, New York, United States, New York
Co-Investments: 2
Tiverton Advisors
North America, North Carolina, United States, Raleigh
Co-Investments: 1
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 3
CIG Spectrum Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Middleland Capital
North America, District of Columbia, United States, Washington
Co-Investments: 1
Innova Memphis
North America, Tennessee, United States, Memphis
Co-Investments: 1
E
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2

What are some of recent deals done by Albany Capital?

leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series DAug 6, 2024
Sherlock Biosciences

Cambridge, Massachusetts, United States

Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.

BiotechnologyHealth CareHealth DiagnosticsLife Science
Series BMar 8, 2022
Amount Raised: $80,000,000
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series BApr 16, 2020
Growers

Garner, North Carolina, United States

Growers develops a platform that helps ag retailers, advisors, and farmers to work better together.

AgricultureFarmingProductivity ToolsRetailSoftware
Series AAug 6, 2018
Amount Raised: $5,000,000
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series AJul 27, 2015
Amount Raised: $20,513,571